{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T22:46:32Z","timestamp":1776206792288,"version":"3.50.1"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T00:00:00Z","timestamp":1734307200000},"content-version":"vor","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Epidemiological studies for atomic bomb (A-bomb) survivors clearly demonstrated that A-bomb radiation increased the risk of hematological neoplasms, such as acute and chronic leukemia, and myelodysplastic syndromes (MDS) among survivors. Several studies on MDS among survivors investigated its characteristics, and it seems that MDS among survivors has different features from those seen in de novo MDS and therapy-related MDS. In this short review, we describe the differences of clinical features, chromosomal alterations and genome aberrations among them.<\/jats:p>","DOI":"10.1093\/jrr\/rrae003","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T13:36:37Z","timestamp":1734356197000},"page":"i88-i96","source":"Crossref","is-referenced-by-count":1,"title":["Myelodysplastic syndromes among atomic bomb survivors in Nagasaki: similarities to and differences from <i>de novo<\/i> and therapy-related cases"],"prefix":"10.1093","volume":"65","author":[{"given":"Koji","family":"Ando","sequence":"first","affiliation":[{"name":"Atomic Bomb Disease Institute, Nagasaki University Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, , Nagasaki 852-8523,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Atomic Bomb Disease Institute, Nagasaki University Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, , Nagasaki 852-8523,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,12,16]]},"reference":[{"key":"2024121613363134200_ref1","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1667\/RR2892.1","article-title":"The incidence of leukemia, lymphoma and multiple myeloma among atomic bomb survivors: 1950-2001","volume":"179","author":"Hsu","year":"2013","journal-title":"Radiat Res"},{"key":"2024121613363134200_ref2","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1200\/JCO.2010.31.3080","article-title":"Risk of myelodysplastic syndromes in people exposed to ionizing radiation: a retrospective cohort study of Nagasaki atomic bomb survivors","volume":"29","author":"Iwanaga","year":"2011","journal-title":"J Clin Oncol"},{"key":"2024121613363134200_ref3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","article-title":"Proposals for the classification of the myelodysplastic syndromes","volume":"51","author":"Bennett","year":"1982","journal-title":"Br J Haematol"},{"key":"2024121613363134200_ref4","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1056\/NEJMra1904794","article-title":"Myelodysplastic syndromes","volume":"383","author":"Cazzola","year":"2020","journal-title":"N Engl J Med"},{"key":"2024121613363134200_ref5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"key":"2024121613363134200_ref6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrc.2016.112","article-title":"The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia","volume":"17","author":"Sperling","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"2024121613363134200_ref7","doi-asserted-by":"publisher","first-page":"5909","DOI":"10.2147\/OTT.S101333","article-title":"Therapy-related myeloid neoplasms: clinical perspectives","volume":"11","author":"Fianchi","year":"2018","journal-title":"Onco Targets Ther"},{"key":"2024121613363134200_ref8","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/leu.2017.323","article-title":"Risk of developing chronic myeloid neoplasms in well-differentiated thyroid cancer patients treated with radioactive iodine","volume":"32","author":"Molenaar","year":"2018","journal-title":"Leukemia"},{"key":"2024121613363134200_ref9","doi-asserted-by":"publisher","first-page":"djt462","DOI":"10.1093\/jnci\/djt462","article-title":"Risk for developing myelodysplastic syndromes in prostate cancer patients definitively treated with radiation","volume":"106","author":"Mukherjee","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"2024121613363134200_ref10","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.3390\/ijerph9082875","article-title":"Leukemia and benzene","volume":"9","author":"Snyder","year":"2012","journal-title":"Int J Environ Res Public Health"},{"key":"2024121613363134200_ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-023-03686-9","article-title":"Real-world data of MDS and CMML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11)","volume":"119","author":"Usuki","year":"2024","journal-title":"Int J Hematol"},{"key":"2024121613363134200_ref12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s12185-023-03677-w","article-title":"Real-world data of AML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11)","volume":"119","author":"Usuki","year":"2023","journal-title":"Int J Hematol"},{"key":"2024121613363134200_ref13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.beha.2019.02.007","article-title":"Clinicopathological aspects of therapy-related acute myeloid leukemia and myelodysplastic syndrome","volume":"32","author":"Chua","year":"2019","journal-title":"Best Pract Res Clin Haematol"},{"key":"2024121613363134200_ref14","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nature13968","article-title":"Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia","volume":"518","author":"Wong","year":"2015","journal-title":"Nature"},{"key":"2024121613363134200_ref15","doi-asserted-by":"publisher","first-page":"103607","DOI":"10.1016\/j.critrevonc.2022.103607","article-title":"Diagnosis and treatment of therapy-related acute myeloid leukemia","volume":"171","author":"Strickland","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"key":"2024121613363134200_ref16","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/nature08851","article-title":"Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia","volume":"464","author":"Raaijmakers","year":"2010","journal-title":"Nature"},{"key":"2024121613363134200_ref17","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"2024121613363134200_ref18","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"key":"2024121613363134200_ref19","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.stem.2018.10.004","article-title":"PPM1D mutations drive clonal Hematopoiesis in response to cytotoxic chemotherapy","volume":"23","author":"Hsu","year":"2018","journal-title":"Cell Stem Cell"},{"key":"2024121613363134200_ref20","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1038\/s41591-020-1008-z","article-title":"Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes","volume":"26","author":"Bernard","year":"2020","journal-title":"Nat Med"},{"key":"2024121613363134200_ref21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.maturitas.2012.02.009","article-title":"Long-term follow-up of atomic bomb survivors","volume":"72","author":"Sakata","year":"2012","journal-title":"Maturitas"},{"key":"2024121613363134200_ref22","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/bjh.15050","article-title":"Chromosomal analysis of myelodysplastic syndromes among atomic bomb survivors in Nagasaki","volume":"180","author":"Horai","year":"2018","journal-title":"Br J Haematol"},{"key":"2024121613363134200_ref23","first-page":"849","article-title":"Growth and differentiation of circulating hemopoietic stem cells with atomic bomb irradiation-induced chromosome abnormalities","volume":"16","author":"Amenomori","year":"1988","journal-title":"Exp Hematol"},{"key":"2024121613363134200_ref24","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1200\/JCO.2011.35.6394","article-title":"New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge","volume":"30","author":"Schanz","year":"2012","journal-title":"J Clin Oncol"},{"key":"2024121613363134200_ref25","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1200\/JCO.2011.38.7340","article-title":"Acute myeloid leukemia and myelodysplastic syndromes after radiation therapy are similar to de novo disease and differ from other therapy-related myeloid neoplasms","volume":"30","author":"Nardi","year":"2012","journal-title":"J Clin Oncol"},{"key":"2024121613363134200_ref26","doi-asserted-by":"publisher","first-page":"358","DOI":"10.3324\/haematol.2019.219386","article-title":"Genome analysis of myelodysplastic syndromes among atomic bomb survivors in Nagasaki","volume":"105","author":"Taguchi","year":"2020","journal-title":"Haematologica"},{"key":"2024121613363134200_ref27","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1182\/blood-2003-09-3074","article-title":"High incidence of somatic mutations in the AML1\/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia","volume":"103","author":"Harada","year":"2004","journal-title":"Blood"},{"key":"2024121613363134200_ref28","doi-asserted-by":"publisher","first-page":"12605","DOI":"10.1038\/ncomms12605","article-title":"Mutational signatures of ionizing radiation in second malignancies","volume":"7","author":"Behjati","year":"2016","journal-title":"Nat Commun"},{"key":"2024121613363134200_ref29","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1667\/RR3231","article-title":"Stable intrachromosomal biomarkers of past exposure to densely ionizing radiation in several chromosomes of exposed individuals","volume":"162","author":"Mitchell","year":"2004","journal-title":"Radiat Res"}],"container-title":["Journal of Radiation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jrr\/article-pdf\/65\/Supplement_1\/i88\/61199303\/rrae003.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jrr\/article-pdf\/65\/Supplement_1\/i88\/61199303\/rrae003.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T13:36:39Z","timestamp":1734356199000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jrr\/article\/65\/Supplement_1\/i88\/7924266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":29,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2024,12,16]]},"published-print":{"date-parts":[[2024,12,15]]}},"URL":"https:\/\/doi.org\/10.1093\/jrr\/rrae003","relation":{},"ISSN":["0449-3060","1349-9157"],"issn-type":[{"value":"0449-3060","type":"print"},{"value":"1349-9157","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2024,12]]}}}